 | • レポートコード：QY20ST-06818 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のトキソイドワクチン市場について種類別（一価破傷風トキソイド（TT）、ジフテリア、破傷風、百日咳（DTaP）、ジフテリアおよび破傷風（DT））、用途別（病院、診療所、政府機関、研究、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・トキソイドワクチン市場の概要 ・世界の主要地域別トキソイドワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のトキソイドワクチン市場規模2015-2026：種類別（一価破傷風トキソイド（TT）、ジフテリア、破傷風、百日咳（DTaP）、ジフテリアおよび破傷風（DT）） ・世界のトキソイドワクチン市場規模2015-2026：用途別（病院、診療所、政府機関、研究、その他） ・トキソイドワクチンの北米市場規模2015-2020 ・トキソイドワクチンのヨーロッパ市場規模2015-2020 ・トキソイドワクチンの中国市場規模2015-2020 ・トキソイドワクチンの日本市場規模2015-2020 ・トキソイドワクチンの東南アジア市場規模2015-2020 ・トキソイドワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・トキソイドワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・トキソイドワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Toxoid Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Toxoid Vaccines market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, are safe for use in vaccines.
When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Toxoid Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Toxoid Vaccines industry.
Based on our recent survey, we have several different scenarios about the Toxoid Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Toxoid Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Toxoid Vaccines market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Toxoid Vaccines market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Toxoid Vaccines market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Toxoid Vaccines market. The report also includes nautical information, where it shows Toxoid Vaccines market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Toxoid Vaccines market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Toxoid Vaccines market.
Geographical Analysis:
Based on region, the global Toxoid Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Toxoid Vaccines market are
GlaxoSmithKline
Merck
Pfizer
Sanofi Pasteur
AstraZeneca
Bharat Biotech
Shenzhen Kangtai Biological Products
Bausch Health
Emergent Biosolutions
Astellas Pharma
Panacea Biotec
Segment by Type
Monovalent Tetanus Toxoid (TT)
Diphtheria
Tetanus
Pertussis (DTaP)
Diphtheria and Tetanus (DT)
Segment by Application
Hospitals And Clinics
Government Organizations
Research
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Toxoid Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Toxoid Vaccines market.
• The market share of the global Toxoid Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Toxoid Vaccines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Toxoid Vaccines market.
1 Toxoid Vaccines Market Overview
1.1 Toxoid Vaccines Product Scope
1.2 Toxoid Vaccines Segment by Type
1.2.1 Global Toxoid Vaccines Sales by Type (2020-2026)
1.2.2 Monovalent Tetanus Toxoid (TT)
1.2.3 Diphtheria
1.2.4 Tetanus
1.2.5 Pertussis (DTaP)
1.2.6 Diphtheria and Tetanus (DT)
1.3 Toxoid Vaccines Segment by Application
1.3.1 Global Toxoid Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Hospitals And Clinics
1.3.3 Government Organizations
1.3.4 Research
1.3.5 Others
1.4 Toxoid Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Toxoid Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Toxoid Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Toxoid Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Toxoid Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the Toxoid Vaccines Industry
1.5.1.1 Toxoid Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Toxoid Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Toxoid Vaccines Players to Combat Covid-19 Impact
2 Toxoid Vaccines Estimate and Forecast by Region
2.1 Global Toxoid Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Toxoid Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Toxoid Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Toxoid Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Toxoid Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Toxoid Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Toxoid Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Toxoid Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Toxoid Vaccines Estimates and Projections (2015-2026)
2.4.3 China Toxoid Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Toxoid Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Toxoid Vaccines Estimates and Projections (2015-2026)
2.4.6 India Toxoid Vaccines Estimates and Projections (2015-2026)
3 Global Toxoid Vaccines Competition Landscape by Players
3.1 Global Top Toxoid Vaccines Players by Sales (2015-2020)
3.2 Global Top Toxoid Vaccines Players by Revenue (2015-2020)
3.3 Global Toxoid Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Toxoid Vaccines as of 2019)
3.4 Global Toxoid Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Toxoid Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Toxoid Vaccines Players (Opinion Leaders)
4 Global Toxoid Vaccines Market Size by Type
4.1 Global Toxoid Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Toxoid Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Toxoid Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Toxoid Vaccines Price by Type (2014-2020)
4.2 Global Toxoid Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Toxoid Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Toxoid Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Toxoid Vaccines Price Forecast by Type (2021-2026)
5 Global Toxoid Vaccines Market Size by Application
5.1 Global Toxoid Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Toxoid Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Toxoid Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Toxoid Vaccines Price by Application (2015-2020)
5.2 Global Toxoid Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Toxoid Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Toxoid Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Toxoid Vaccines Price Forecast by Application (2021-2026)
3 North America Toxoid Vaccines Market Facts & Figures
3.2 North America Toxoid Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Toxoid Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Toxoid Vaccines Sales Market Share by Application (2015-2020)
4 Europe Toxoid Vaccines Market Facts & Figures
4.2 Europe Toxoid Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Toxoid Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Toxoid Vaccines Sales Market Share by Application (2015-2020)
5 China Toxoid Vaccines Market Facts & Figures
5.2 China Toxoid Vaccines Sales Market Share by Company (2015-2020)
5.3 China Toxoid Vaccines Sales Market Share by Type (2015-2020)
5.4 China Toxoid Vaccines Sales Market Share by Application (2015-2020)
6 Japan Toxoid Vaccines Market Facts & Figures
6.2 Japan Toxoid Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Toxoid Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Toxoid Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Toxoid Vaccines Market Facts & Figures
7.2 Southeast Asia Toxoid Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Toxoid Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Toxoid Vaccines Sales Market Share by Application (2015-2020)
8 India Toxoid Vaccines Market Facts & Figures
8.2 India Toxoid Vaccines Sales Market Share by Company (2015-2020)
8.3 India Toxoid Vaccines Sales Market Share by Type (2015-2020)
8.4 India Toxoid Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Toxoid Vaccines Business
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Toxoid Vaccines Corporation Information
12.1.2 GlaxoSmithKline Toxoid Vaccines Business Overview and Total Revenue
12.1.3 GlaxoSmithKline Toxoid Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Toxoid Vaccines Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Merck
12.2.1 Merck Toxoid Vaccines Corporation Information
12.2.2 Merck Toxoid Vaccines Business Overview and Total Revenue
12.2.3 Merck Toxoid Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Toxoid Vaccines Products Offered
12.2.5 Merck Recent Development
12.3 Pfizer
12.3.1 Pfizer Toxoid Vaccines Corporation Information
12.3.2 Pfizer Toxoid Vaccines Business Overview and Total Revenue
12.3.3 Pfizer Toxoid Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Toxoid Vaccines Products Offered
12.3.5 Pfizer Recent Development
12.4 Sanofi Pasteur
12.4.1 Sanofi Pasteur Toxoid Vaccines Corporation Information
12.4.2 Sanofi Pasteur Toxoid Vaccines Business Overview and Total Revenue
12.4.3 Sanofi Pasteur Toxoid Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Pasteur Toxoid Vaccines Products Offered
12.4.5 Sanofi Pasteur Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Toxoid Vaccines Corporation Information
12.5.2 AstraZeneca Toxoid Vaccines Business Overview and Total Revenue
12.5.3 AstraZeneca Toxoid Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 AstraZeneca Toxoid Vaccines Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Bharat Biotech
12.6.1 Bharat Biotech Toxoid Vaccines Corporation Information
12.6.2 Bharat Biotech Toxoid Vaccines Business Overview and Total Revenue
12.6.3 Bharat Biotech Toxoid Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bharat Biotech Toxoid Vaccines Products Offered
12.6.5 Bharat Biotech Recent Development
12.7 Shenzhen Kangtai Biological Products
12.7.1 Shenzhen Kangtai Biological Products Toxoid Vaccines Corporation Information
12.7.2 Shenzhen Kangtai Biological Products Toxoid Vaccines Business Overview and Total Revenue
12.7.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Shenzhen Kangtai Biological Products Toxoid Vaccines Products Offered
12.7.5 Shenzhen Kangtai Biological Products Recent Development
12.8 Bausch Health
12.8.1 Bausch Health Toxoid Vaccines Corporation Information
12.8.2 Bausch Health Toxoid Vaccines Business Overview and Total Revenue
12.8.3 Bausch Health Toxoid Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bausch Health Toxoid Vaccines Products Offered
12.8.5 Bausch Health Recent Development
12.9 Emergent Biosolutions
12.9.1 Emergent Biosolutions Toxoid Vaccines Corporation Information
12.9.2 Emergent Biosolutions Toxoid Vaccines Business Overview and Total Revenue
12.9.3 Emergent Biosolutions Toxoid Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Emergent Biosolutions Toxoid Vaccines Products Offered
12.9.5 Emergent Biosolutions Recent Development
12.10 Astellas Pharma
12.10.1 Astellas Pharma Toxoid Vaccines Corporation Information
12.10.2 Astellas Pharma Toxoid Vaccines Business Overview and Total Revenue
12.10.3 Astellas Pharma Toxoid Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Astellas Pharma Toxoid Vaccines Products Offered
12.10.5 Astellas Pharma Recent Development
12.11 Panacea Biotec
12.11.1 Panacea Biotec Toxoid Vaccines Corporation Information
12.11.2 Panacea Biotec Toxoid Vaccines Business Overview and Total Revenue
12.11.3 Panacea Biotec Toxoid Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Panacea Biotec Toxoid Vaccines Products Offered
12.11.5 Panacea Biotec Recent Development
13 Toxoid Vaccines Manufacturing Cost Analysis
13.1 Toxoid Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Toxoid Vaccines
13.4 Toxoid Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Toxoid Vaccines Distributors List
14.3 Toxoid Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Toxoid Vaccines Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Toxoid Vaccines Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Toxoid Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Toxoid Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Toxoid Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market Toxoid Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Toxoid Vaccines Sales (K Units) by Region (2015-2020)
Table 10. Global Toxoid Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global Toxoid Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Toxoid Vaccines Revenue Share by Region (2015-2020)
Table 13. Global Toxoid Vaccines Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Toxoid Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Toxoid Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Toxoid Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Toxoid Vaccines (K Units) of Key Companies (2015-2020)
Table 18. Global Toxoid Vaccines Sales Share by Company (2015-2020)
Table 19. Global Toxoid Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Toxoid Vaccines Revenue Share by Company (2015-2020)
Table 21. Global Toxoid Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Toxoid Vaccines as of 2019)
Table 22. Global Toxoid Vaccines Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Toxoid Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers Toxoid Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Toxoid Vaccines Players
Table 27. Global Toxoid Vaccines Sales (K Units) by Type (2015-2020)
Table 28. Global Toxoid Vaccines Sales Share by Type (2015-2020)
Table 29. Global Toxoid Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Toxoid Vaccines Price (K Units) by Type (2015-2020)
Table 31. Global Toxoid Vaccines Sales Share by Type (2021-2026)
Table 32. Global Toxoid Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Toxoid Vaccines Revenue Share by Type (2021-2026)
Table 34. Global Toxoid Vaccines Price (K Units) by Type (2021-2026)
Table 35. Global Toxoid Vaccines Sales (K Units) by Application (2015-2020)
Table 36. Global Toxoid Vaccines Sales Share by Application (2015-2020)
Table 37. Global Toxoid Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Toxoid Vaccines Price (K Units) by Application (2015-2020)
Table 39. Global Toxoid Vaccines Sales (K Units) by Application (2021-2026)
Table 40. Global Toxoid Vaccines Sales Share by Application (2021-2026)
Table 41. Global Toxoid Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Toxoid Vaccines Revenue Share by Application (2021-2026)
Table 43. Global Toxoid Vaccines Price (K Units) by Application (2021-2026)
Table 44. United States Toxoid Vaccines Sales (K Units) by Company (2015-2020)
Table 45. United States Toxoid Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States Toxoid Vaccines Sales (K Units) by Type (2015-2020)
Table 47. United States Toxoid Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States Toxoid Vaccines Sales (K Units) by Application (2015-2020)
Table 49. United States Toxoid Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe Toxoid Vaccines Sales (K Units) by Company (2015-2020)
Table 51. Europe Toxoid Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe Toxoid Vaccines Sales (K Units) by Type (2015-2020)
Table 53. Europe Toxoid Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe Toxoid Vaccines Sales (K Units) by Application (2015-2020)
Table 55. Europe Toxoid Vaccines Sales Market Share by Type (2015-2020)
Table 56. China Toxoid Vaccines Sales (K Units) by Company (2015-2020)
Table 57. China Toxoid Vaccines Sales Market Share by Company (2015-2020)
Table 58. China Toxoid Vaccines Sales (K Units) by Type (2015-2020)
Table 59. China Toxoid Vaccines Sales Market Share by Type (2015-2020)
Table 60. China Toxoid Vaccines Sales (K Units) by Application (2015-2020)
Table 61. China Toxoid Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan Toxoid Vaccines Sales (K Units) by Company (2015-2020)
Table 63. Japan Toxoid Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan Toxoid Vaccines Sales (K Units) by Type (2015-2020)
Table 65. Japan Toxoid Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan Toxoid Vaccines Sales (K Units) by Application (2015-2020)
Table 67. Japan Toxoid Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Toxoid Vaccines Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Toxoid Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Toxoid Vaccines Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Toxoid Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Toxoid Vaccines Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Toxoid Vaccines Sales Market Share by Application (2015-2020)
Table 74. India Toxoid Vaccines Sales (K Units) by Company (2015-2020)
Table 75. India Toxoid Vaccines Sales Market Share by Company (2015-2020)
Table 76. India Toxoid Vaccines Sales (K Units) by Type (2015-2020)
Table 77. India Toxoid Vaccines Sales Market Share by Type (2015-2020)
Table 78. India Toxoid Vaccines Sales (K Units) by Application (2015-2020)
Table 79. India Toxoid Vaccines Sales Market Share by Application (2015-2020)
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline Toxoid Vaccines Product
Table 84. GlaxoSmithKline Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Merck Toxoid Vaccines Product
Table 89. Merck Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Pfizer Toxoid Vaccines Product
Table 94. Pfizer Recent Development
Table 95. Sanofi Pasteur Corporation Information
Table 96. Sanofi Pasteur Description and Business Overview
Table 97. Sanofi Pasteur Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Sanofi Pasteur Toxoid Vaccines Product
Table 99. Sanofi Pasteur Recent Development
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. AstraZeneca Toxoid Vaccines Product
Table 104. AstraZeneca Recent Development
Table 105. Bharat Biotech Corporation Information
Table 106. Bharat Biotech Description and Business Overview
Table 107. Bharat Biotech Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Bharat Biotech Toxoid Vaccines Product
Table 109. Bharat Biotech Recent Development
Table 110. Shenzhen Kangtai Biological Products Corporation Information
Table 111. Shenzhen Kangtai Biological Products Description and Business Overview
Table 112. Shenzhen Kangtai Biological Products Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Shenzhen Kangtai Biological Products Toxoid Vaccines Product
Table 114. Shenzhen Kangtai Biological Products Recent Development
Table 115. Bausch Health Corporation Information
Table 116. Bausch Health Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Bausch Health Description and Business Overview
Table 118. Bausch Health Toxoid Vaccines Product
Table 119. Bausch Health Recent Development
Table 120. Emergent Biosolutions Corporation Information
Table 121. Emergent Biosolutions Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Emergent Biosolutions Description and Business Overview
Table 123. Emergent Biosolutions Toxoid Vaccines Product
Table 124. Emergent Biosolutions Recent Development
Table 125. Astellas Pharma Corporation Information
Table 126. Astellas Pharma Description and Business Overview
Table 127. Astellas Pharma Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Astellas Pharma Toxoid Vaccines Product
Table 129. Astellas Pharma Recent Development
Table . Panacea Biotec Corporation Information
Table . Panacea Biotec Description and Business Overview
Table . Panacea Biotec Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Panacea Biotec Toxoid Vaccines Product
Table . Panacea Biotec Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Toxoid Vaccines Distributors List
Table 138. Toxoid Vaccines Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Toxoid Vaccines Product Picture
Figure 2. Global Toxoid Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Toxoid Vaccines Market Share by Application in 2020 & 2026
Figure 6. Hospitals And Clinics Examples
Figure 7. Government Organizations Examples
Figure 8. Research Examples
Figure 9. Others Examples
Figure 10. Global Toxoid Vaccines Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Toxoid Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Toxoid Vaccines Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Toxoid Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Toxoid Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Toxoid Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Toxoid Vaccines Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Toxoid Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Toxoid Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Toxoid Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Toxoid Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Toxoid Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Toxoid Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Toxoid Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Toxoid Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Toxoid Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Toxoid Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Toxoid Vaccines Players Market Share by Revenue in Toxoid Vaccines 2015 & 2019
Figure 28. Toxoid Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Toxoid Vaccines Revenue Share by Type (2015-2020)
Figure 30. Global Toxoid Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Toxoid Vaccines Revenue Share by Application (2015-2020)
Figure 32. Global Toxoid Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Toxoid Vaccines Sales Market Share by Type in 2019
Figure 34. United States Toxoid Vaccines Sales Market Share by Type in 2019
Figure 35. Europe Toxoid Vaccines Sales Market Share by Company in 2019
Figure 36. Europe Toxoid Vaccines Sales Market Share by Type in 2019
Figure 37. Europe Toxoid Vaccines Sales Market Share by Application in 2019
Figure 38. China Toxoid Vaccines Sales Market Share by Company in 2019
Figure 39. China Toxoid Vaccines Sales Market Share by Type in 2019
Figure 40. China Toxoid Vaccines Sales Market Share by Application in 2019
Figure 41. Japan Toxoid Vaccines Sales Market Share by Company in 2019
Figure 42. Japan Toxoid Vaccines Sales Market Share by Type in 2019
Figure 43. Japan Toxoid Vaccines Sales Market Share by Application in 2019
Figure 44. Southeast Asia Toxoid Vaccines Sales Market Share by Company in 2019
Figure 45. Southeast Asia Toxoid Vaccines Sales Market Share by Type in 2019
Figure 46. Southeast Asia Toxoid Vaccines Sales Market Share by Application in 2019
Figure 47. India Toxoid Vaccines Sales Market Share by Company in 2019
Figure 48. India Toxoid Vaccines Sales Market Share by Type in 2019
Figure 49. India Toxoid Vaccines Sales Market Share by Application in 2019
Figure 50. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bharat Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Shenzhen Kangtai Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Emergent Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Panacea Biotec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Toxoid Vaccines
Figure 63. Manufacturing Process Analysis of Toxoid Vaccines
Figure 64. Toxoid Vaccines Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
犬用ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Dog Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data …- 猫用ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Cat Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data …
- 組換えベクターワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Recombinant Vector Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides…
- 破傷風の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tetanus market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tetanus market report provides a deta…
- デング熱ワクチンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Dengue Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dengue Vaccines market report…